Edited by Edward D. Ball, John Lister, and Ping Law. 757 pp., illustrated. Philadelphia, Churchill Livingstone, 2000. $299.50. ISBN 0-443-07622-7.
Recent developments are revolutionizing our understanding ofthe potential therapeutic role of what used to be called bonemarrow transplantation but is now called hematopoietic stem-celltherapy. Over the past three decades, much empirical knowledgehas been accumulated to provide a sound basis for the optimaluse of this approach in the treatment of hematopoietic cancers,especially acute myelogenous leukemia, Hodgkin's disease andother lymphomas, and (more recently) multiple myeloma. Thisapproach has also been used in the treatment of some solid tumors,most notably breast cancer, for which its value is still indispute because of poor accrual in . . . [Full Text of this Article]
Previous
